GRAPPA
Home
About GRAPPA
Goals
Accomplishments
Committees
GRAPPA FAQ
Join GRAPPA
Meetings
Resources
Member Login
Member ID


Password



Join GRAPPA
If you are a health care professional interested in psoriasis and psoriatic arthritis, please join us in our fight to raise awareness.
   
Committees
Executive Committee
Executive Committee Committee Members:
Philip Mease, President
Wolf-Henning Boehncke, Vice President
Professor Gerald Krueger, Secretary
Amit Garg
MD, FRCPC Dafna Gladman
Arthur Kavanaugh
Costantino Pitzalis
Administration
Administration Committee Members:
Wolf-Henning Boehncke
Pam Love
Governance
This committee was established to oversee the development and introduction of a set of bylaws for the GRAPPA organisation. Initial discussions took place in June 2005 followed by a review of governance arrangements of other organisations. Following this review a preliminary set of bylaws was drafted and discussed among the committee. The next draft was presented at the GRAPPA meeting adjacent to ACR in San Diego and a final set of bylaws posted on the GRAPPA website for those unable to attend the meeting. After further comments the GRAPPA membership were asked to approve these bylaws in January 2006. A majority of registered GRAPPA members approved these bylaws – 104/195 members voting to adopt them, with one voting against. Elections for Executive Committee and Steering Committee members have taken place and the results will be posted shortly.
Governance Committee Members:
Philip Helliwell, Chair
Wolf-Henning Boehncke
MD, FRCPC Dafna Gladman
Arthur Kavanaugh
Philip Mease
Christopher Ritchlin
Co-Morbidities Committee
Co-Morbidities Committee Committee Members:
Wolf-Henning Boehncke, Chair
MD, FRCPC Dafna Gladman
Elaine Husni
Dr. Siba Raychaudhuri
Def. Musculosekletal Inflam
Definition of Musculoskeletal Inflammation
Def. Musculosekletal Inflam Committee Members:
Amit Garg, Chair
MD, FRCPC Dafna Gladman
Philip Mease
Disease Activity & Response
Disease Activity and Response Measure Project
Disease Activity & Response Committee Members:
Philip Helliwell, Chair
Oliver FitzGerald
Philip Mease
Education Committee
Education Committee Committee Members:
Philip Mease, Chair
MD April Armstrong
Amit Garg
MD, FRCPC Dafna Gladman
Genetics/Genomics Committee
Genetics/Genomics Committee Committee Members:
Proton Rahman, Chair
MD, FRCPC Dafna Gladman
Global Outreach Committee
Global Outreach Committee Committee Members:
Philip Mease, Chair
Luis Espinoza
Dr Ying Ying Leung
Histology/Immunohistochemistry
The Psoriatic Arthritis Immunopathologic Mechanisms (PSAIM) group has 25 members, both rheumatologists and dermatologists, from 13 different centers. PSAIM was established to further develop collaborative research in the fields of psoriasis and psoriatic arthritis skin and synovium. An initial inventory has been completed which has documented what archival material is available for future study. Under the leadership of D. Baeten, archival material from 52 spondyloarthropathy patients, including 16 with psoriatic arthritis, has been examined for markers of treatment response (Arthritis Rheum; in press). Analysis showed that changes in synovial macrophage subsets, PMN, and MMP3 expression best reflected clinical response to treatment after 12 weeks. In a further study from Goedkoop et al., significant reductions in T cell and macrophage markers were seen with anti-TNF therapy but no evidence of increased cell apoptosis could be demonstrated. It has now been agreed that a prospective study should be undertaken to examine changes in tissue (skin and synovium) biomarkers at earlier time-points which should predict clinical responses to anti-TNF therapy in PsA. Biopsies of skin and synovium will be obtained at baseline and at 4 weeks and clinical responses will be determined at 12 weeks.
Histology/Immunohistochemistry Committee Members:
Oliver FitzGerald, Chair
Identification of PsA
Identification of PsA Committee Members:
MD, FRCPC Dafna Gladman, Chair
Abrar Qureshi, Chair
Imaging
Imaging Committee Members:
Gurjit Kaeley, Chair
Mikkel Ostergaard
OMERACT
OMERACT Committee Members:
Philip Mease, Chair
Oliver FitzGerald
MD, FRCPC Dafna Gladman
Philip Helliwell
Vibeke Strand
Peripheral Joint Assessment
Peripheral Joint Assessment Committee Members:
MD, FRCPC Dafna Gladman, Chair
Philip Mease
Publications
Publications Committee Members:
MD, FRCPC Dafna Gladman, Chair
Wolf-Henning Boehncke
Dr. Vinod Chandran
Dr Laura Coates
Oliver FitzGerald
Amit Garg
Philip Helliwell
Arthur Kavanaugh
Professor Gerald Krueger
Philip Mease
Costantino Pitzalis
Abrar Qureshi
Proton Rahman
Christopher Ritchlin
Vibeke Strand
QOL/Function/Participation
QOL/Function/Participation Committee Members:
William Taylor, Chair
A.O. Adebajo
Vibeke Strand
Douglas Veale
Registries
Registries Committee Members:
Paulo Gisondi, Chair
Research
Research Committee Members:
Philip Helliwell, Chair
Peter Nash
Eric Ruderman
Spinal Assessment
Spinal Assessment Committee Members:
Philip Helliwell
Ennio Lubrano
Antonio Marchesoni
Ignazio Olivieri
Steering Committee
Steering Committee Committee Members:
Wolf-Henning Boehncke
Alberto Cauli
Luis Espinoza
Oliver FitzGerald
Assoc Prof Peter Foley
Amit Garg
Asst. Prof Joel Gelfand
MD, FRCPC Dafna Gladman
Alice Gottlieb
Arthur Kavanaugh
Ennio Lubrano
Walter Maksymowych
Neil McHugh
Philip Mease
Peter Nash
Ignazio Olivieri
Costantino Pitzalis
Abrar Qureshi
Proton Rahman
Vibeke Strand
Professor Mona Ståhle
Translational ResearchBiomaker
Translational ResearchBiomaker Committee Members:
MD, FRCPC Dafna Gladman, Chair
Dr. Vinod Chandran
Oliver FitzGerald
Treatment Guidelines
The goal of this committee is to review the best scientific evidence and ultimately to develop evidenced based guidelines for the treatment of Psoriatic Arthritis. Also, an important goal is to identify areas that need further research and clarification. It is accepted that the goals of treatment are to: improve the signs and symptoms of disease, prevent damage and disability, optimize functional status and quality of life, avoid toxicity.
Treatment Guidelines Committee Members:
Arthur Kavanaugh, Chair
MD, FRCPC Dafna Gladman
Philip Mease
Video Project
Video Project Committee Members:
MD Kristina Callis Duffin, Chair
Philip Mease
Website
The GRAPPA Website Committee consists of Dr. Neil McHugh (representing UK), Dr. Philip Mease (representing USA), Dr. Kim Papp (representing Canada), Dr. Enrique Soriano (representing Argentina) and Dr. Peter Nash (representing Australia) a truly International collaboration. The website functions as GRAPPA face to the world with a public section that will include links to helpful educational material and to patient support and advocacy groups. Members can log in via secured username and password to access past presentations and an interactive email and chat room facility. The GRAPPA website outlines GRAPPA’s mission statement and goals as well as highlights GRAPPA’s history, describing the inaugural meeting in New York and subsequent meetings at OMERACT, ACR & EULAR. Accomplishments including the Supplement in the Annals Rheumatic Diseases are listed. GRAPPA committees are listed and membership described. Upcoming meetings are highlighted. Via an interactive map of the world GRAPPA members in individual countries are readily found so that the public and members can have access to the latest information regarding research projects and where to contact GRAPPA members. Whilst a simple site, it aims to be a practical and functional resource for public and membership alike and a window to the International GRAPPA collaboration.
Website Committee Members:
Peter Nash, Chair
MD Kristina Callis Duffin
MD, FRCPC Dafna Gladman
Neil McHugh
Philip Mease
Enrique Soriano